<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00705030000005</udiDi>
    <basicUdiDi>0705030_CELLEX_EPP_Acc_3P</basicUdiDi>
    <tradeName>Therakos Cellex Photopheresis System Procedural Kit</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Therakos Development Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000052224</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B030204</emdnCode>
    <emdnDescription>EXTRACORPOREAL PHOTOCHAEMOTHERAPY OR PHOTOPHERESIS DEVICES AND KITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CLXSP-I</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T22:14:01.603Z</lastUpdated>
  </row>
  <row>
    <udiDi>00705030000012</udiDi>
    <basicUdiDi>0705030_CELLEX_EPP_Acc_3P</basicUdiDi>
    <tradeName>Therakos Cellex Photopheresis System Procedural Kit</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Therakos Development Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000052224</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B030204</emdnCode>
    <emdnDescription>EXTRACORPOREAL PHOTOCHAEMOTHERAPY OR PHOTOPHERESIS DEVICES AND KITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CLXSP-U</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-06T17:18:04.727Z</lastUpdated>
  </row>
  <row>
    <udiDi>00705030000029</udiDi>
    <basicUdiDi>0705030_CELLEX_EPP_Acc_3P</basicUdiDi>
    <tradeName>Therakos Cellex Photopheresis System Procedural Kit</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Therakos Development Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000052224</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B030204</emdnCode>
    <emdnDescription>EXTRACORPOREAL PHOTOCHAEMOTHERAPY OR PHOTOPHERESIS DEVICES AND KITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CLXCC-I</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-06T17:18:04.702Z</lastUpdated>
  </row>
  <row>
    <udiDi>00705030000036</udiDi>
    <basicUdiDi>0705030_CELLEX_EPP_Acc_3P</basicUdiDi>
    <tradeName>Therakos Cellex Photopheresis System Procedural Kit</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Therakos Development Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000052224</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B030204</emdnCode>
    <emdnDescription>EXTRACORPOREAL PHOTOCHAEMOTHERAPY OR PHOTOPHERESIS DEVICES AND KITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CLXCC-U</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-06T17:18:04.648Z</lastUpdated>
  </row>
</eudamedExport>